Surgeons to operate robot from 1,500 miles away to remove liver parasites
NCT ID NCT07551063
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial will test whether surgeons in Chengdu can safely remove liver parasites from 10 patients in Lhasa (3,650m altitude) using a 5G-connected robot. The goal is to see if the remote surgery can be completed without major issues. If it works, it could bring expert care to remote regions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Toumai™ robotic surgical system with 5G network
- What this could lead to
- If successful, this could show that expert robotic surgery can be delivered to remote, high-altitude areas, expanding access to life-saving liver surgery.
- What could go wrong
- This is a very early, small study (10 people) with no control group. Technical failures, network delays, or surgical complications could occur, and results may not apply to other settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC ECHINOCOCCOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
West China Hospital, Sichuan University
Chengdu, Sichuan / 四川, 614000, China